Welcome To ONE Regenerative Health

ONE Regenerative Health is pleased to have selected an ​Amnion Suspension  Allograft (ASA)​ provider with a culture of scientific advancement, a strong  commitment to product safety, efficacy and innovation and is dedicated to clinical  research.

This ASA injection provider has the first published, multicenter randomized clinical trial evaluating the efficacy of an ASA injection for the  treatment of symptomatic knee osteoarthritis.  

Amnion Suspension Allograft (ASA) injections

A cryopreserved single-injection therapy that reduces inflammation and pain in  Osteoarthritis (OA). (ASA injections are an effective treatment for the nonoperative  management of symptomatic OA and other Orthopedic applications for chronic pain  and prolonged disease state). 

Read More

What makes up the Amnion Suspension Allograft ReNu​

ReNu consists of amniotic fluid cells and micronized amniotic membrane, and  contains three key factors: 

– Extracellular matrix (ECM) particles, including hyaluronic acid 
– Amniotic fluid cells 
– A rich supply of anti-inflammatory cytokines, and regenerative growth  factors 

“ReNu is a non-steroidal treatment and a single-injection therapy. ASA  modulates inflammation without an acute inflammatory response.”

What can ASA be used for? 

Conditions We Treat

  • Achilles Tendonitis/Tendonosis
  • Ankle Sprain or Tear
  • Back Pain
  • Golfer’s Elbow
  • Hip Pain
  • Knee Injury and Pain
  • Knee MeniscaL Tears
  • Low Back Pain (Lumbar Spine)
  • Neck Pain (Cervical Spine)
  • Shoulder Pain
  • Tennis Elbow

Benefits of Regenerative Medicine: 

– Minimally Invasive Outpatient procedure 
– Avoids surgery 
– Minimal to no downtime 
– Non-steroidal 
– Lower costs than surgery 
– Promotes your own body to heal and regenerate 

Note: Results can vary by patient

Is ReNu® Safe?

The amniotic tissues in ReNu are collected from fully consented mothers undergoing scheduled caesarean section births of full-term healthy babies. Donors are tested for relevant communicable diseases by an FDA registered laboratory, and Organogenesis only releases tissue for transplantation that has negative or non-reactive results for all tested communicable diseases. After screening, the amniotic tissue is aseptically processed in a controlled, clean environment following strict technical quality assurance standards.

Read More

Get In Touch


Dr. Burak Ozgur, MD, FAANS

Double board certified Neurosurgery and Spine Surgery
Combined Fellowship Neurosurgery-Orthopedic Spine Surgery

(949) 383-4190


Dr. Alfred Beshai, MD

Double board certified Pain Medicine and Anesthesiology

(949) 398-0106

Font Resize
Location Text Us